Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of Sunday, July 26, 2026.
Forward PE Ratio (N/A) = Close Price ($54.07) / Consensus Forward EPS ($-8.66)
FORWARD PE RATIO
N/A
Moderna, Inc.
Market Cap
$21.45B
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Moderna, Inc. (MRNA) | $21.45B | N/A |
| STERIS plc (STE)vs › | $20.86B | 20.99 |
| United Therapeutics Corporation (UTHR)vs › | $22.43B | 18.96 |
| BioNTech SE (BNTX)vs › | $22.59B | N/A |
| Viatris Inc. (VTRS)vs › | $20.08B | 7.03 |
| West Pharmaceutical Services, Inc. (WST)vs › | $23.10B | 36.71 |
| Incyte Corporation (INCY)vs › | $23.51B | 14.68 |
| Labcorp Holdings Inc. (LH)vs › | $24.34B | 16.47 |
| Waters Corporation (WAT)vs › | $24.42B | 25.80 |
| Quest Diagnostics Incorporated (DGX)vs › | $25.15B | 20.59 |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus next-FY EPS
At today's $54.07 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| 2026-12-31 | $-8.66 | $-9.51 – $-7.50 | 16 | n/m |
| 2027-12-31 | $-4.77 | $-6.30 – $-0.09 | 16 | n/m |
| 2028-12-31 | $-2.73 | $-4.33 – $0.64 | 15 | n/m |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
